. Disponible-sur, asp?ref_id=bilan- demo&page=donnees-detaillees/bilan-demo/pop_age3.htm [2] HAS ; Legrain S.; Consommation médicamenteuse chez le sujet âgé : consommation, prescription, iatrogénie et observance, Disponible sur

J. Albarede, J. Ankri, and D. Balas, Vieillissement ; Collège national des enseignants de gériatre, 2005.

S. Legrain and S. Et-lacaille, Prescription médicamenteuse du sujet âgé, pp.1-7, 2005.

E. Bayliss, M. Bayliss, W. Jr, J. Steiner, and J. , Predicting declines in physical function in persons with multiple chronic médical conditions: what we can learn from the medical problem list, Health and Quality of Life Outcomes, vol.2, issue.1, pp.47-55, 2004.
DOI : 10.1186/1477-7525-2-47

P. Michel, C. Minodier, and C. Et-moty-monnereau, Les évènements indésirables graves dans les établissements de santé: fréquence, évitabilité et acceptabilité; Enquête nationale sur les événement indésirables liés aux soins (ENEIS); Direction de la recherche, de l'évaluation, des études et des statistiques (DREES), mai 2011, Disponible sur

M. Pirmohamed, S. James, S. Meakin, C. Green, A. Scott et al., Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, vol.329, issue.7456
DOI : 10.1136/bmj.329.7456.15

B. Bégaud and E. D. Costagliola, Rapport sur la surveillance et la promotion du bon usage de médicaments en France, Disponible sur

L. Auvray and C. Et-sermet, Consommations et prescriptions pharmaceutiques chez les personnes âgées; un état des lieux, Gérontologie et Société, pp.13-27, 2002.

G. Bouvenot and P. Villani, Apport des essais pr??-AMM ?? la connaissance du risque iatrog??ne chez la personne ??g??e, Th??rapie, vol.59, issue.2, pp.233-239, 2004.
DOI : 10.2515/therapie:2004045

S. Legrain, Prescription to elderly patients: reducing underuse and adverse drug reactions and improving adherence; Bulletin de l'Académie Nationale de, Medecine, vol.191, pp.259-69, 2007.

M. Naunton, G. Peterson, and M. Bleasel, Overuse of proton pump inhibitors

S. Legrain, Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study

M. Beers, Explicit criteria for determining potentially inappropriate medication use by the elderly. An update; Archives of Internal Medecine, pp.1531-1536, 1997.

N. Salles-montaudon, A. Fourrier, and J. Dartigues, Evolution des traitements médicamenteux des personnes âgées vivant à domicile; La Revue de Médecine Interne, août, vol.21, issue.8, pp.664-671, 2000.

M. Lachamp, V. Pauly, and R. Saubuc, Impact de la modification des prescriptions chez les sujets ??g??s hospitalis??s en service de court s??jour g??riatrique en termes de co??t, La Revue de M??decine Interne, vol.33, issue.9
DOI : 10.1016/j.revmed.2012.05.013

I. Ponson and A. Et-pechu, Prescription médicamenteuse chez le sujet âgé: étude des modifications thérapeutiques au cours d'un séjour en gériatrie chez 221 patients hospitalisés dans la région lyonnaise, pp.11-19, 2014.

. Société-nationale-française-de-gastro-entérologie, Conférence de Consensus Helicobacter pylori -Révision 1999 [en ligne] Disponible sur

L. Kueiyu, J. Hernandez-diaz, S. , G. Rodriguez, and L. , Acid Suppressants Reduce Risk of Gastrointestinal Bleeding in Patients on Antithrombotic or Anti-Inflammatory Therapy, Gastroenterology, vol.141, pp.71-79, 2011.

M. Scheiman, J. Devereaux, P. Herlitz, and J. , Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON), Heart, vol.97, issue.10, pp.797-802, 2011.
DOI : 10.1136/hrt.2010.217547

M. Würtz, L. Erik, . Grove, D. Steen, and A. Kristensen, The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease, Heart, vol.96, issue.5, pp.368-371, 2010.
DOI : 10.1136/hrt.2009.181107

K. Fock, P. Katelaris, K. Sugano, T. Ang, R. Hunt et al., infection, Journal of Gastroenterology and Hepatology, vol.130, issue.17, pp.1587-600, 2009.
DOI : 10.1111/j.1440-1746.2009.05982.x

URL : https://hal.archives-ouvertes.fr/hal-01403673

A. Lanas, J. Fuentes, and R. Benito, Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin ; Alimentary and pharmacology Therapeutics, pp.779-786, 2002.

I. Junichi, S. Yoshifumi, H. Akira, and M. Et-yasushi, Clinical features of gastroduodénal injury associated with long term low-dose aspirin therapy, World Journal of Gastroenterology, vol.19, issue.11, pp.1673-1682, 2013.

A. Lanas and J. Et-scheiman, Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment; Current Medical Research and Opinion, pp.163-173, 2007.
DOI : 10.1185/030079907x162656

F. Chan, S. Chung, B. Suen, and Y. Lee, Infection Who Are Taking Low-Dose Aspirin or Naproxen, New England Journal of Medicine, vol.344, issue.13, pp.967-973, 2001.
DOI : 10.1056/NEJM200103293441304

A. Desilets, N. Asal, and K. Dunican, Considerations for the Use of Proton-Pump Inhibitors in Older Adults, The Consultant Pharmacist, vol.27, issue.2, pp.114-134, 2012.
DOI : 10.4140/TCP.n.2012.114

Y. Yang, J. Lewis, and S. Epstein, Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA, vol.296, issue.24, pp.2947-53, 2006.
DOI : 10.1001/jama.296.24.2947

Y. Lau and N. Ahmed, Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.92, issue.1, pp.67-79, 2012.
DOI : 10.1002/PHAR.1007

L. Targownik, L. Lix, C. Metge, H. Prior, S. Leung et al., Use of proton pump inhibitors and risk of osteoporosis-related fractures, Canadian Medical Association Journal, vol.179, issue.4, pp.319-345, 2008.
DOI : 10.1503/cmaj.071330

C. Ruhl, A. Sonneberg, and J. Everhart, Hospitalization with Respiratory Disease Following Hiatal Hernia and Reflux Esophagitis in a Prospective, Population-Based Study, Annals of Epidemiology, vol.11, issue.7
DOI : 10.1016/S1047-2797(01)00236-8

K. Zedtwitz-liebenstein, C. Wenisch, and S. Patruta, Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity*, Critical Care Medicine, vol.30, issue.5, pp.1118-1122, 2002.
DOI : 10.1097/00003246-200205000-00026

C. Eom, C. Jeon, J. Lim, E. Cho, S. Park et al., Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis, Canadian Medical Association Journal, vol.183, issue.3, pp.310-319, 2011.
DOI : 10.1503/cmaj.092129

R. Laheij, M. Sturkenboom, and R. Hassing, Risk of Community-Acquired Pneumonia and Use of Gastric Acid???Suppressive Drugs, JAMA, vol.292, issue.16, pp.1955-60, 2004.
DOI : 10.1001/jama.292.16.1955

S. Herzig, M. Howell, L. Ngo, and E. Marcantonio, Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia, JAMA, vol.301, issue.20, pp.2120-2128, 2009.
DOI : 10.1001/jama.2009.722

. Eurichdt, C. Sadonski, and S. Simpson, Recurrent Community-acquired Pneumonia in Patients Starting Acid-suppressing Drugs, The American Journal of Medicine, vol.123, issue.1, pp.47-53, 2010.
DOI : 10.1016/j.amjmed.2009.05.032

D. Lowe, M. Mamdani, and A. Kopp, Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based Study, Clinical Infectious Diseases, vol.43, issue.10, pp.1272-1278, 2006.
DOI : 10.1086/508453

S. Poutanen and A. Simor, Clostridium difficile-associated diarrhea in adults, Canadian Medical Association Journal, vol.171, issue.1
DOI : 10.1503/cmaj.1031189

S. Dial, J. Delaney, and A. Barkun, Use of Gastric Acid???Suppressive Agents and the Risk of Community-Acquired <EMPH TYPE="ITAL">Clostridium difficile</EMPH>???Associated Disease, JAMA, vol.294, issue.23, pp.2989-95, 2005.
DOI : 10.1001/jama.294.23.2989

C. Kwok, A. Arthur, and C. Anibueze, Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis, The American Journal of Gastroenterology, vol.63, issue.7, pp.1011-1020, 2012.
DOI : 10.1186/1471-2334-11-194

A. Vuagniaux and P. Vollenweider, Approche diagnostique de l'hyponatrémie; Revue Médicale Suisse, pp.2074-2079, 2010.

G. Liamis, H. Milionis, and M. Et-elisaf, A Review of Drug-Induced Hyponatremia, American Journal of Kidney Diseases, vol.52, issue.1
DOI : 10.1053/j.ajkd.2008.03.004

M. Kuipers and H. Thang, Arntzenius AB; Hypomagnesaemia due to use of proton pump inhibitors-a review, The Netherlands Journal of Medicine, vol.67, pp.169-72, 2009.

T. Cundy and A. Et-dissanayake, Severe hypomagnesaemia in long-term users of proton-pump inhibitors, Clinical Endocrinology, vol.137, issue.2, pp.338-379, 2008.
DOI : 10.1111/j.1365-2265.2008.03194.x

M. Delgado, S. Calleja, L. Suarez, and J. Et-pascual, Recurrent confusional episodes associated with hypomagnesaemia due to esomeprazol, Case Reports, vol.2013, issue.aug05 1, 2013.
DOI : 10.1136/bcr-2013-200501

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762399

C. Hogenauer and H. Hammer, Maldigestion and malabsorption; Sleisenger and Fordtran's Gastrointestinal and Liver Disease; Philadelphia 9 ème Edition, p.101

D. Elzen, W. Groeneveld, Y. De-ruijter, and W. , Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals; Alimentary and Pharmacology Therapeutics, pp.491-497, 2008.

T. Dharmarajan, M. Kanagala, and P. Murakonda, Do acid-lowering agants affect vitamin B12 status in older adults?, JAMA, vol.9, pp.162-169, 2008.
DOI : 10.1016/j.jamda.2007.10.004

R. Lamberts, W. Creutzfeld, and H. Struber, Long-term omeprazole therapy in peptic ulcer disease, Gastroenterology, vol.105, issue.6, pp.1356-70, 1993.
DOI : 10.1016/0016-5085(93)91106-R

N. Havu, H. Mattson, and L. Et-ekman, Enterochromaffin-Like Cell Carcinoids in the Rat Gastric Mucosa following Long-Term Administration of Ranitidine, Digestion, vol.45, issue.4, pp.189-95, 1990.
DOI : 10.1159/000200245

P. Haastrup and M. Paulsen, Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study, European Journal of General Practice, vol.12, issue.4, pp.290-293, 2014.
DOI : 10.3109/13814788.2014.905535

. Disponible-sur, has-sante.fr/portail/upload/docs

S. Duc and N. Et-salles, Trop d'IPP au long cours chez le sujet âgé?, La Revue du Praticien Médecine Générale, vol.885, issue.26, pp.604-606, 2012.

I. Marie, A. Moutot, and A. Tharrasse, Adéquation aux recommandations sur la prescription des IPP; la Revue Médecine interne, pp.86-93, 2007.

T. Grimmsmann, U. Schwabe, and W. Et-himmel, The influence of hospitalisation on drug prescription in primary care ??? a large-scale follow-up study, European Journal of Clinical Pharmacology, vol.115, issue.8, pp.783-90, 2007.
DOI : 10.1007/s00228-007-0325-1

S. Ferchichi and V. Antoine, Le bon usage des médicaments chez la personnes âgée; la Revue de Médecine Interne, pp.582-590, 2004.

M. Coutellier, S. Mouly, and V. Delcey, Que deviennent les modifications th??rapeutiques d??cid??es au cours d???une hospitalisation en m??decine interne??? ??tude prospective fran??aise monocentrique sur 2??mois, La Revue de M??decine Interne, vol.35, issue.8, pp.498-502, 2014.
DOI : 10.1016/j.revmed.2014.04.014

M. Jones, S. Greenfield, S. Jowett, C. Bradley, and R. Seal, Proton pump inhibitors: a study of GP's prescribing; Family Practice, pp.333-341, 2001.

B. Glintborg, S. Andersen, and K. Et-dalhoff, Insufficient communication about medication use at the interface between hospital and primary care; Quality and Safety in Health Care, Fevrier, vol.16, issue.1, pp.34-39, 2007.

P. Haastrup, M. Paulsen, and J. Zwisler, Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study, European Journal of General Practice, vol.12, issue.4
DOI : 10.3109/13814788.2014.905535

J. Dent, H. El-serag, M. Wallander, and S. Et-johansson, Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut, vol.54, issue.5, pp.710-717, 2005.
DOI : 10.1136/gut.2004.051821

J. Pandolfino, M. Kwiatek, and P. Kahrilas, The Pathophysiologic Basis for Epidemiologic Trends in Gastroesophageal Reflux Disease, Gastroenterology Clinics of North America, vol.37, issue.4, pp.827-870, 2008.
DOI : 10.1016/j.gtc.2008.09.009

N. Krol, M. Wensing, and F. Haaijer-ruskamp, Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial, Alimentary Pharmacology and Therapeutics, vol.49, issue.8, pp.917-939, 2004.
DOI : 10.1016/S0277-9536(00)00114-3

M. Oudjhani and O. Foison, et Astier A; Do the elderly know about their treatment

A. Mudge, R. Shakhovskoy, and A. Et-karrasch, Quality of transitions in older medical patients with frequent readmissions: Opportunities for improvement, European Journal of Internal Medicine, vol.24, issue.8, pp.779-83, 2013.
DOI : 10.1016/j.ejim.2013.08.708

H. Garasen and R. Et-johnsen, The quality of communication about older patients between hospital physicians and general practitioners: a panel study assessment, BMC Health Services Research, vol.319, issue.1, p.133, 2007.
DOI : 10.1136/bmj.319.7217.1127

K. Still, A. Davis, and A. Chilipko, Evaluation of a Pharmacy-Driven Inpatient Discharge Counseling Service: Impact on 30-Day Readmission Rates, The Consultant Pharmacist, vol.28, issue.12, pp.775-85, 2013.
DOI : 10.4140/TCP.n.2013.775